Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 213-147-2 | CAS number: 927-07-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Description of key information
In an acute oral toxicits study with TBPPI in rats a combinded LD50 value of 4169 mg/kg bw was determined. The 4 hours LC50 was calculated to be 7.79 mg/L with 95 % confidence limits of 5.89 and 10.28 mg/L (exposure to mist). In an acute dermal toxicits study with TBPPI in rabbits a LD50 value of 2500 mg/kg bw was determined.
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- July 1978
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study with acceptable restrictions
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- other: OECD TG 201
- Principles of method if other than guideline:
- 5 doses were applied orally by gavage to rats, which were observed the following 14 days.
- GLP compliance:
- no
- Test type:
- standard acute method
- Limit test:
- no
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Harlan Industries, Inc. Indianapolis; Indiana
- Weight at study initiation: 200 to 248 g
- Fasting period before study: overnight period before administration of test item
- Housing: 5 rats per sex per cage
- Diet: ad libitum
- Water: ad libitum
- Acclimation period: 8 days - Route of administration:
- oral: gavage
- Vehicle:
- corn oil
- Details on oral exposure:
- VEHICLE
- Amount of vehicle: 10 mL to 20 mL
MAXIMUM DOSE VOLUME APPLIED: 20 mL - Doses:
- 1585; 2512; 3980; 6308 and 10000 mg/kg bw
- No. of animals per sex per dose:
- 5 per sex per dose
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations: during the first 4 hours, at 24 h and daily for a total of 14 days
- Frequency of weighing: prior to dosing and on day 7 and 14
- Necropsy of survivors performed: no - Key result
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- 4 169 mg/kg bw
- Based on:
- test mat.
- 95% CL:
- > 3 587 - < 4 845
- Mortality:
- 1585 mg/kg bw : 0/10
2512 mg/kg bw: 0/10
3980 mg/kg bw: 4/10
6308 mg/kg bw: 10/10
10000 mg/kg bw: 10/10 - Clinical signs:
- other: no data
- Gross pathology:
- no data
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- In an acute oral toxicits study with TBPPI in rats a combinded LD50 value of 4169 mg/kg bw was determined.
- Executive summary:
Twenty-five male and twenty- five female rats of the Sprague Dawley strain were used for an acute oral toxicity study. The test material was administered orally by gavage as a solution in corn oil at the following dosage levels to male and female rats: 1585; 2512; 3980 and 10000 mg/kg bw. Five rats of each sex were used at each dosage level. All the dosage levels were administered at a volume of 10 mL/ kg except for the high dose, which was administed at a volume of 20 mL/kg.
The rats were observed for mortality, only, during the first four hours following dosing, at 24 hours and daily thereafter for a total of 14 days. Body weights were recorded immediately prior to dosing and at 7 and 14 days.
No animal died at the two lowest dosage levels. Four females died at the dosage level of 3980 mg/kg bw and all animals died in the two highest dosage levels.
The combined male and female acute oral LD50 value was 4169 mg/kg bw and the 95th confidence interval was 3587 - 4845 mg/kg bw.
Reference
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 4 169 mg/kg bw
- Quality of whole database:
- sumilar to OECD 401/non-GLP
Acute toxicity: via inhalation route
Link to relevant study records
- Endpoint:
- acute toxicity: inhalation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1978
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study with acceptable restrictions
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 403 (Acute Inhalation Toxicity)
- Deviations:
- not specified
- Principles of method if other than guideline:
- Rats were exposed to a vapour atmosphere of the test item in an acute inhalation toxicity study.
- GLP compliance:
- no
- Test type:
- acute toxic class method
- Limit test:
- no
- Species:
- rat
- Strain:
- other: Charles River CD
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Weight at study initiation: male: 216 - 292 grams and female: 209 - 286 grams
- Housing: individually in compartmented wire-mesh exposure cages
- Diet: purina laboratory chow ad libitum
- Water: water ad libitum
- Acclimation period: at least week - Route of administration:
- inhalation: aerosol
- Type of inhalation exposure:
- whole body
- Vehicle:
- air
- Details on inhalation exposure:
- GENERATION OF TEST ATMOSPHERE / CHAMBER DESCRIPTION
- Exposure apparatus: a FMI Lab pump or a Harvard infusion pump
- Exposure chamber volume: 160 L
- Source and rate of air: 8 L/min
TEST ATMOSPHERE
- Brief description of analytical method used: The invidual concentratins of the compound in the chamber atmosphere were calculated from the ratio of the rate of liquid dissemination to the rate of total chamber airflow. - Analytical verification of test atmosphere concentrations:
- yes
- Duration of exposure:
- 4 h
- Concentrations:
- 2.0, 4.2, 8.3, 17.1 mg/L
- No. of animals per sex per dose:
- 5
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: Individual body weights were recorded prior to the 4 hour exposure and at 24 and 48 hours in order to detect any latent effects following the exposure.
- Necropsy of survivors performed: yes - Key result
- Sex:
- male/female
- Dose descriptor:
- LC50
- Effect level:
- 7.79 mg/L air (analytical)
- Based on:
- test mat.
- 95% CL:
- 5.89 - 10.28
- Exp. duration:
- 4 h
- Sex:
- male
- Dose descriptor:
- LC50
- Effect level:
- 5.07 mg/L air (analytical)
- Based on:
- test mat.
- 95% CL:
- 3.81 - 6.75
- Exp. duration:
- 4 h
- Sex:
- female
- Dose descriptor:
- LC50
- Effect level:
- > 8.3 - < 17.1 mg/L air (analytical)
- Based on:
- test mat.
- Exp. duration:
- 4 h
- Remarks on result:
- other: by inspection only as data were not suitable for calculation
- Mortality:
- At the concentration of 2.0 mg/L, no mortality was observed. At the concentration of 4.2 mg/L, one male rat died. At the concentration of 8.3 mg/L, five male rats died. At the concentration of 17.1 mg/L, all animals died.
- Clinical signs:
- other: Slight to marked dyspnea was observed in all groups of rats at the concentrations above 2.0 mg/L.
- Body weight:
- All rats lost weight following the exposures.
- Gross pathology:
- Necropsy of the dead rats revealed reddened lungs with dark red patches and discoloration of the liver.
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- The 4 hours LC50 was calculated to be 7.79 mg/l with 95 % confidence limits of 5.89 and 10.28 mg/L (aerosol exposure).
- Executive summary:
Tert-butyl peroxypivalate was tested in an acute inhalation toxicity study. Four groups of 5 male and 5 female rats were exposed to an aerosol atmosphere of tert-butyl peroxypivalate. The four "metered" concentrations were 17.1, 8.3, 4.2, 2.0 mg/L respectively. Slight to marked dyspnea and deaths were observed in all groups of rats at concentrations above 2.0 mg/L. All rats lost weight following the exposures. Necropsy of the dead rats revealed reddened lungs with dark red patches and discoloration of the liver. The 4 hours LC50 was calculated to be 7.79 mg/l with 95 % confidence limits of 5.89 and 10.28 mg/L.
Reference
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed
- Dose descriptor:
- LC50
- Value:
- 7 790 mg/m³ air
- Physical form:
- inhalation: aerosol
- Quality of whole database:
- similar to OECD 403/non-GLP
Acute toxicity: via dermal route
Link to relevant study records
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- July 1978
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- test procedure in accordance with national standard methods with acceptable restrictions
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 402 (Acute Dermal Toxicity)
- Deviations:
- not specified
- Principles of method if other than guideline:
- 5 doses were applied once only to the backs of rabbits for 24 hours and were observed the following 14 days.
- GLP compliance:
- no
- Test type:
- standard acute method
- Limit test:
- no
- Species:
- rabbit
- Strain:
- New Zealand White
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: H.A.R.E. Rabbits for Research, Hewitt, New Jersey
- Weight at study initiation: 2300 to 2805 g
- Housing: individually in hanging wire-mesh cages
- Diet: ad libitum
- Water: ad libitum
- Acclimation period: 12 days - Type of coverage:
- occlusive
- Vehicle:
- unchanged (no vehicle)
- Details on dermal exposure:
- TEST SITE
- % coverage: 20 - 30% of body surface
- Type of wrap if used: gauze banding
REMOVAL OF TEST SUBSTANCE
- Washing: tepid tap water
- Time after start of exposure: 24 hours - Duration of exposure:
- 24 hours
- Doses:
- 1250; 2500; 5000; 10000 and 20000 mg/kg bw
- No. of animals per sex per dose:
- 2 animals per sex per dose
- Control animals:
- not required
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations: 24 hours and daily for 14 days
- Frequency of weighing: prior to test material administration and on day 7 and 14
- Necropsy of died animals performed: yes - Key result
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- 2 500 mg/kg bw
- Based on:
- test mat.
- 95% CL:
- > 1 301 - < 4 806
- Mortality:
- 1250 mg/kg bw: 1/4
2500 mg/kg bw: 1/4
5000 mg/kg bw: 4/4
10000 mg/kg bw: 4/4
20000 mg/kg bw : 4/4 - Clinical signs:
- other: Animals exposed up to 2500 mg/kg bw showed dermal irritations like moderate to marked erythema, edema, desquamation and necrosis, which were not reversible until day 14.
- Gross pathology:
- The animals died during the test exposed to doses higher than 5000 mg/ kg bw showed dermal irritation and ulceration and hyperemia of mucose of the stomach and discoloration of the liver. Males were more sensitive to the test item than females.
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- In an acute dermal toxicity study with TBPPI in rabbits a LD50 value of 2500 mg/kg bw was determined.
- Executive summary:
Twenty male and twenty female New Zealand White rabbits were used for an acute dermal toxicity study with TBPPI. The rabbits were divided into five groups of 2 male and 2 female rabbits each. The hair was removed from the back of each rabbit (20 -30% of the body surface) with an electric clipper. The test material was applied once only to the backs of the rabbits at the following dosage levels: 1250; 2500; 5000; 10000 and 20000 mg/ kg bw. Following dosing, the application sites were wrapped with gauze bandaging and overwrapped with Saran Wrap. 24 hours following application, the bandages were removed and the test sites were washed with tepid tap water. The rabbits were observed at 24 hours and daily thereafter for a total of 14 days for pharmacotoxic signs, mortality and dermal irritation. Body weights were recorded immediately prior to the test material administration and at 7 and 14 days of the observation period. All rabbits which died on study were subjected to gross necropsy examination.
All animals exposed to 5000 mg/kg bw and higher died during the testing period. One female and one male rabbit died in the lowest and the 2500 mg/kg bw dose level respectivly. In all surviving animals moderate to marked dermal irritation and necrosis occured and were not reversible until 14 days. Necropsy of died animals showed ulceration and hyperemia of the mucosa of the stomach and discoloration of the liver. No adverse effects on body weights of surviving animals could be observed.
The acute dermal LD50 values were 2500 mg/kg bw in males and females and the 95th confidence limits were 1250 - 5000 mg/kg bw in males and 625 - 10000 mg/kg bw in females.
Reference
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 2 500 mg/kg bw
- Quality of whole database:
- similar to OECD 402/GLP
Additional information
Oral:
Twenty-five male and twenty- five female rats of the Sprague Dawley strain were used for an acute oral toxicity study. The test material was administered orally by gavage as a solution in corn oil at the following dosage levels to male and female rats: 1585; 2512; 3980 and 10000 mg/kg bw. Five rats of each sex were used at each dosage level. All the dosage levels were administered at a volume of 10 mL/ kg except for the high dose, which was administed at a volume of 20 mL/kg. The rats were observed for mortality, only, during the first four hours following dosing, at 24 hours and daily thereafter for a total of 14 days. Body weights were recorded immediately prior to dosing and at 7 and 14 days. No animal died at the two lowest dosage levels. Four females died at the dosage level of 3,980 mg/kg bw and all animals died in the two highest dosage levels. The combined male and female acute oral LD50 value was 4169 mg/kg bw and the 95th confidence interval was 3587 - 4845 mg/kg bw.
Inhalation:
Tert-butyl peroxypivalate was tested in an acute inhalation toxicity study. Four groups of 5 male and 5 female rats were exposed to an aerosol atmosphere of tert-butyl peroxypivalate. The four "metered" concentrations were 17.1, 8.3, 4.2, 2.0 mg/L respectively. Slight to marked dyspnea and deaths were observed in all groups of rats at concentrations above 2.0 mg/L. All rats lost weight following the exposures. Necropsy of the dead rats revealed reddened lungs with dark red patches and discoloration of the liver. The 4 hours LC50 was calculated to be 7.79 mg/L with 95 % confidence limits of 5.89 and 10.28 mg/L. Furthermore, an acute inhalation toxicity study, published by Gage J.C. (1970) is available. Tert- butyl peroxypivalate was irritant to the eyes and respiratory tract but no mortality was observed with a concentration of 200 ppm (corresponding to 1.45 mg/L).
Dermal:
Twenty male and twenty female New Zealand White rabbits were used for an acute dermal toxicity study with TBPPI. The rabbits were divided into five groups of 2 male and 2 female rabbits each. The hair was removed from the back of each rabbit (20 -30% of the body surface) with an electric clipper. The test material was applied once only to the backs of the rabbits at the following dosage levels: 1250; 2500; 5000; 10000 and 20000 mg/ kg bw. Following dosing, the application sites were wrapped with gauze bandaging and overwrapped with Saran Wrap. 24 hours following application, the bandages were removed and the test sites were washed with tepid tap water. The rabbits were observed at 24 hours and daily thereafter for a total of 14 days for pharmacotoxic signs, mortality and dermal irritation. Body weights were recorded immediately prior to the test material administration and at 7 and 14 days of the observation period. All rabbits which died on study were subjected to gross necropsy examination. All animals exposed to 5000 mg/kg bw and higher died during the testing period. One female and one male rabbit died in the lowest and the 2500 mg/kg bw dose level respectivly. In all surviving animals moderate to marked dermal irritation and necrosis occured and were not reversible until 14 days. Necropsy of died animals showed ulceration and hyperemia of the mucosa of the stomach and discoloration of the liver. No adverse effects on body weights of surviving animals could be observed. The acute dermal LD50 values were 2500 mg/kg bw in males and females and the 95th confidence limits were 1250 - 5000 mg/kg bw in males and 625- 10000 mg/kg bw in females.
Justification for classification or non-classification
Classification, Labelling, and Packaging Regulation (EC) No 1272/2008
The available experimental test data are reliable and suitable for classification purposes under Regulation (EC) No 1272/2008. Based on available data the test item is not classified for acute toxicity according to Regulation (EC) No 1272/2008 (CLP), as amended for the eighteenth time in Regulation (EU) 2022/692.
The substance contains up to 26 % isododecane as stabilizer which is classified as aspiration toxicity Cat. 1. Based on the kinematic viscosity of the substance and in accordance with the section 3.10.3 of Annex I of Regulation (EC) No 1272/2008 (CLP) the substance has to be classified with as aspiration toxicity Cat. 1, H304: May be fatal if swallowed and enters airways.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
